KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Inventory (2016 - 2025)

Zimmer Biomet Holdings has reported Inventory over the past 17 years, most recently at $2.3 billion for Q4 2025.

  • Quarterly results put Inventory at $2.3 billion for Q4 2025, up 2.29% from a year ago — trailing twelve months through Dec 2025 was $2.3 billion (up 2.29% YoY), and the annual figure for FY2025 was $2.3 billion, up 2.29%.
  • Inventory for Q4 2025 was $2.3 billion at Zimmer Biomet Holdings, down from $2.5 billion in the prior quarter.
  • Over the last five years, Inventory for ZBH hit a ceiling of $2.5 billion in Q2 2021 and a floor of $2.1 billion in Q2 2022.
  • Median Inventory over the past 5 years was $2.3 billion (2023), compared with a mean of $2.3 billion.
  • Biggest five-year swings in Inventory: fell 16.2% in 2022 and later rose 11.08% in 2023.
  • Zimmer Biomet Holdings' Inventory stood at $2.1 billion in 2021, then decreased by 0.04% to $2.1 billion in 2022, then grew by 11.08% to $2.4 billion in 2023, then fell by 6.28% to $2.2 billion in 2024, then grew by 2.29% to $2.3 billion in 2025.
  • The last three reported values for Inventory were $2.3 billion (Q4 2025), $2.5 billion (Q3 2025), and $2.5 billion (Q2 2025) per Business Quant data.